Article Details
Retrieved on: 2020-10-18 14:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Akron <b>Biotechnology</b> today announced it has signed an agreement with Synairgen plc (LSE: SNG) for the provision of SNG001, Synairgen's ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here